P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTS

Aim: Ambulatory monitoring of central blood pressure (BP) is a new technique for evaluation of antihypertensive drugs efficacy. The aim of the study was to assess changes in ambulatory brachial and central BP after indapamide SR adjunction to treatment regimen in hypertensive patients. Methods: Ind...

Full description

Bibliographic Details
Main Authors: Y. Kotovskaya, O. Kravtsova, Z. Kobalava
Format: Article
Language:English
Published: BMC 2013-11-01
Series:Artery Research
Online Access:https://www.atlantis-press.com/article/125939061/view
_version_ 1817982989360955392
author Y. Kotovskaya
O. Kravtsova
Z. Kobalava
author_facet Y. Kotovskaya
O. Kravtsova
Z. Kobalava
author_sort Y. Kotovskaya
collection DOAJ
description Aim: Ambulatory monitoring of central blood pressure (BP) is a new technique for evaluation of antihypertensive drugs efficacy. The aim of the study was to assess changes in ambulatory brachial and central BP after indapamide SR adjunction to treatment regimen in hypertensive patients. Methods: Indapamide SR 1,5 mg was added to 21 hypertensive patients (9 male, age 62 years) with uncontrolled hypertension (clinic BP >140/90 mmHg, 24-h BP >130/80 mmHg and/or daytime BP>135/85 mmHg) after 8 weeks treatment with combination of an ACE inhibitor and a calcium channel blocker. ABPM was done before and after 4 weeks of indapamide SR adjunction with BPLab VASOTENS (“OOO Petr Telegin”, Nizhniy Novgorod, Russia) brachial oscillometric device which allows to derive aortic BP and augmentation index (AIx). Brachial and aortic BP changes were evaluated. p<0,05 was considered significant. Results: Significant (p<0,05) decrease in 24-h, day- and nighttime BP after 4 weeks of indapamide SR adjunction was observed: for brachial systolic pressure, respectively, from 147±13 to 138±10, from 148±13 to 139±10, from 145±15 to 134±14 mmHg, for aortic systolic pressure, respectively, from 137±12 to 128±9, from 137±12 to 128±9, from 137±14 to 126±13 mmHg. AIx@HR75 bpm decreased significantly (p<0,05) also: 24-h AIx from 1,8±24,9 to −11,1±17,5%, daytime AIx from −2,3±25,6 to −15,7±18,1%, night-time from 15,4±21,7 to 1,8±19,5%. Conclusion: Indapamide SR adjunction to combination therapy with combination of an ACE inhibitor and a calcium channel blocker results in significant decrease in brachial and aortic systolic pressure as well as in decrease in aortic pulse pressure augmentation. Decrease in aortic pulse pressure augmentation is observed during both day- and night-time.
first_indexed 2024-04-13T23:28:03Z
format Article
id doaj.art-977f1d2a35fe4e509d164873313b2aa8
institution Directory Open Access Journal
issn 1876-4401
language English
last_indexed 2024-04-13T23:28:03Z
publishDate 2013-11-01
publisher BMC
record_format Article
series Artery Research
spelling doaj.art-977f1d2a35fe4e509d164873313b2aa82022-12-22T02:25:00ZengBMCArtery Research1876-44012013-11-0171010.1016/j.artres.2013.10.175P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTSY. KotovskayaO. KravtsovaZ. KobalavaAim: Ambulatory monitoring of central blood pressure (BP) is a new technique for evaluation of antihypertensive drugs efficacy. The aim of the study was to assess changes in ambulatory brachial and central BP after indapamide SR adjunction to treatment regimen in hypertensive patients. Methods: Indapamide SR 1,5 mg was added to 21 hypertensive patients (9 male, age 62 years) with uncontrolled hypertension (clinic BP >140/90 mmHg, 24-h BP >130/80 mmHg and/or daytime BP>135/85 mmHg) after 8 weeks treatment with combination of an ACE inhibitor and a calcium channel blocker. ABPM was done before and after 4 weeks of indapamide SR adjunction with BPLab VASOTENS (“OOO Petr Telegin”, Nizhniy Novgorod, Russia) brachial oscillometric device which allows to derive aortic BP and augmentation index (AIx). Brachial and aortic BP changes were evaluated. p<0,05 was considered significant. Results: Significant (p<0,05) decrease in 24-h, day- and nighttime BP after 4 weeks of indapamide SR adjunction was observed: for brachial systolic pressure, respectively, from 147±13 to 138±10, from 148±13 to 139±10, from 145±15 to 134±14 mmHg, for aortic systolic pressure, respectively, from 137±12 to 128±9, from 137±12 to 128±9, from 137±14 to 126±13 mmHg. AIx@HR75 bpm decreased significantly (p<0,05) also: 24-h AIx from 1,8±24,9 to −11,1±17,5%, daytime AIx from −2,3±25,6 to −15,7±18,1%, night-time from 15,4±21,7 to 1,8±19,5%. Conclusion: Indapamide SR adjunction to combination therapy with combination of an ACE inhibitor and a calcium channel blocker results in significant decrease in brachial and aortic systolic pressure as well as in decrease in aortic pulse pressure augmentation. Decrease in aortic pulse pressure augmentation is observed during both day- and night-time.https://www.atlantis-press.com/article/125939061/view
spellingShingle Y. Kotovskaya
O. Kravtsova
Z. Kobalava
P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTS
Artery Research
title P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTS
title_full P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTS
title_fullStr P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTS
title_full_unstemmed P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTS
title_short P5.27 INDAPAMIDE SR EFFECTS ON AMBULATORY BRACHIAL AND AORTIC PRESSURE IN HYPERTENSIVE PATIENTS
title_sort p5 27 indapamide sr effects on ambulatory brachial and aortic pressure in hypertensive patients
url https://www.atlantis-press.com/article/125939061/view
work_keys_str_mv AT ykotovskaya p527indapamidesreffectsonambulatorybrachialandaorticpressureinhypertensivepatients
AT okravtsova p527indapamidesreffectsonambulatorybrachialandaorticpressureinhypertensivepatients
AT zkobalava p527indapamidesreffectsonambulatorybrachialandaorticpressureinhypertensivepatients